These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
551 related items for PubMed ID: 32297040
21. In Vitro Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak. O'Brien B, Chaturvedi S, Chaturvedi V. Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31932367 [Abstract] [Full Text] [Related]
23. The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris. Shivarathri R, Jenull S, Stoiber A, Chauhan M, Mazumdar R, Singh A, Nogueira F, Kuchler K, Chowdhary A, Chauhan N. mSphere; 2020 Oct 14; 5(5):. PubMed ID: 33055262 [Abstract] [Full Text] [Related]
24. Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface. Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Litvintseva AP. J Clin Microbiol; 2017 Oct 14; 55(10):2996-3005. PubMed ID: 28747370 [Abstract] [Full Text] [Related]
25. Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris. Welsh RM, Sexton DJ, Forsberg K, Vallabhaneni S, Litvintseva A. J Clin Microbiol; 2019 Apr 14; 57(4):. PubMed ID: 30760535 [Abstract] [Full Text] [Related]
26. What do we know about the biology of the emerging fungal pathogen of humans Candida auris? Bravo Ruiz G, Lorenz A. Microbiol Res; 2021 Jan 14; 242():126621. PubMed ID: 33096325 [Abstract] [Full Text] [Related]
27. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, Long L, Isham N, Kovanda L, Borroto-Esoda K, Wring S, Angulo D, Ghannoum M. Antimicrob Agents Chemother; 2017 May 14; 61(5):. PubMed ID: 28223375 [Abstract] [Full Text] [Related]
28. Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance. Escandón P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, Rivera S, Misas E, Duarte C, Moulton-Meissner H, Welsh RM, Parra C, Pescador LA, Villalobos N, Salcedo S, Berrio I, Varón C, Espinosa-Bode A, Lockhart SR, Jackson BR, Litvintseva AP, Beltran M, Chiller TM. Clin Infect Dis; 2019 Jan 01; 68(1):15-21. PubMed ID: 29788045 [Abstract] [Full Text] [Related]
29. Genotypic and phenotypic characterisation of a nosocomial outbreak of Candida auris in Spain during 5 years. Mulet-Bayona JV, Cancino-Muñoz I, Salvador-García C, Tormo-Palop N, Guna-Serrano MDR, Ferrer-Gómez C, Melero-García M, González-Candelas F, Gimeno-Cardona C. Mycoses; 2024 Aug 01; 67(8):e13776. PubMed ID: 39086009 [Abstract] [Full Text] [Related]
35. On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points. Chakrabarti A, Sood P. J Med Microbiol; 2021 Mar 15; 70(3):. PubMed ID: 33599604 [Abstract] [Full Text] [Related]
36. Rapid Detection of ERG11-Associated Azole Resistance and FKS-Associated Echinocandin Resistance in Candida auris. Hou X, Lee A, Jiménez-Ortigosa C, Kordalewska M, Perlin DS, Zhao Y. Antimicrob Agents Chemother; 2019 Jan 15; 63(1):. PubMed ID: 30397051 [Abstract] [Full Text] [Related]
37. New Technologies to Diagnose and Treat a Multidrug-Resistant Candida auris: A Patent Review. Rossato L, Simionatto S, Serafini MR, Alves IA. Mycopathologia; 2022 Dec 15; 187(5-6):535-546. PubMed ID: 36194378 [Abstract] [Full Text] [Related]
38. Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data. Ruiz-Gaitán AC, Cantón E, Fernández-Rivero ME, Ramírez P, Pemán J. Int J Antimicrob Agents; 2019 May 15; 53(5):541-546. PubMed ID: 30769198 [Abstract] [Full Text] [Related]
39. Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method. Helleberg M, Jørgensen KM, Hare RK, Datcu R, Chowdhary A, Arendrup MC. Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015032 [Abstract] [Full Text] [Related]
40. The first invasive Candida auris infection in Taiwan. Tsai YT, Lu PL, Tang HJ, Huang CH, Hung WC, Tseng YT, Lee KM, Lin SY. Emerg Microbes Infect; 2022 Dec 24; 11(1):1867-1875. PubMed ID: 35811508 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]